DAVID V. GOEDDEL - 10 Jun 2022 Form 4 Insider Report for Tenaya Therapeutics, Inc. (TNYA)

Role: Director, 10%+ Owner
Signature: /s/ Jennifer Drimmer Rokovich, Attorney-in-Fact
Issuer symbol: TNYA
Transactions as of: 10 Jun 2022
Transactions value $: $0
Form type: 4
Filing time: 13 Jun 2022, 20:52:47 UTC
Previous filing: 13 Jun 2022
Next filing: 19 Oct 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TNYA	Stock Option (Right to buy)	Award	$0	+39.7K		$0.00	39.7K	10 Jun 2022	Common Stock	39.7K	$5.26	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full upon the first anniversary of the date of grant or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date.

Content

Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full upon the first anniversary of the date of grant or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date.